Publications by authors named "Bryan Cho Wing Li"

Claim this Profile
C
Combined Immunotherapy in Treating Patients with Advanced Hepatocellular Carcinoma.
Karen Hoi Lam Li, Roland Leung, Bryan Cho Wing Li, Tan To Cheung, Thomas Yau

Biomedicines· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A step towards multimodality relief for painful hepatic cancer: the CCTG HE1 trial.
Jeffrey Sum Lung Wong, Roland Leung, Bryan Cho Wing Li, Thomas Yau

Transl Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
David Tak Wai Lui, Chi Ho Lee, Vikki Tang, Carol Ho Yi Fong, Alan Chun Hong Lee, Bryan Cho Wing Li, Karen Siu Ling Lam

Endocr Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Bryan Cho Wing Li, Joanne Chiu, Kit Shing, Gerry Gin Wai Kwok, Vikki Tang

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.
Josephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Bryan Cho Wing Li, Roland Leung

Expert Rev Gastroenterol Hepatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study.
Jeffrey Sum-Lung Wong, Yawen Dong, Vikki Tang, Thomas Leung, Cynthia S Y Yeung, Bryan Cho-Wing Li

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang, Bryan Cho Wing Li, Roland Leung

J Immunother Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis